Light-Hope Diagnostics’ Early Cancer Detection Panel is a PCR-based test utilizing liquid biopsy technology to detect a panel of novel small non-coding RNAs indicative of early-stage cancer. This test offers a non-invasive alternative to traditional diagnostic methods, eliminating the need for cold chain management and significantly reducing diagnostic costs. The panel is designed for use in clinical settings and offers a high degree of sensitivity and specificity.